Dihydrokainic acid（Cat No.:I001721）is a selective inhibitor of the excitatory amino acid transporter 2 (EAAT2), which is responsible for the uptake of the neurotransmitter glutamate into glial cells. By inhibiting EAAT2, dihydrokainic acid increases extracellular glutamate levels, which can be useful in research studying glutamatergic signaling and synaptic transmission. It has been investigated for its potential role in neurological disorders such as epilepsy, Alzheimer’s disease, and other conditions associated with glutamate dysregulation. Dihydrokainic acid’s ability to modulate glutamate levels makes it a valuable tool for neurobiological studies and therapeutic exploration.